- Home
- ALC vs ONC Comparison
ALC vs ONC Comparison
Compare ALC & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALC
- ONC
- Stock Information
- Founded
- ALC 1945
- ONC 2010
- Country
- ALC Switzerland
- ONC Switzerland
- Employees
- ALC N/A
- ONC N/A
- Industry
- ALC Ophthalmic Goods
- ONC Biotechnology: Pharmaceutical Preparations
- Sector
- ALC Health Care
- ONC Health Care
- Exchange
- ALC Nasdaq
- ONC Nasdaq
- Market Cap
- ALC 40.2B
- ONC 34.8B
- IPO Year
- ALC N/A
- ONC N/A
- Fundamental
- Price
- ALC $73.89
- ONC $310.48
- Analyst Decision
- ALC Buy
- ONC Strong Buy
- Analyst Count
- ALC 11
- ONC 10
- Target Price
- ALC $91.41
- ONC $350.00
- AVG Volume (30 Days)
- ALC 2.1M
- ONC 204.1K
- Earning Date
- ALC 11-11-2025
- ONC 11-06-2025
- Dividend Yield
- ALC 0.29%
- ONC N/A
- EPS Growth
- ALC N/A
- ONC N/A
- EPS
- ALC 2.16
- ONC N/A
- Revenue
- ALC $10,025,000,000.00
- ONC $4,562,002,000.00
- Revenue This Year
- ALC $5.94
- ONC $887.89
- Revenue Next Year
- ALC $7.71
- ONC $22.45
- P/E Ratio
- ALC $34.30
- ONC N/A
- Revenue Growth
- ALC 4.04
- ONC 47.33
- 52 Week Low
- ALC $71.55
- ONC $170.99
- 52 Week High
- ALC $99.20
- ONC $355.30
- Technical
- Relative Strength Index (RSI)
- ALC 41.56
- ONC 42.71
- Support Level
- ALC $73.41
- ONC $307.54
- Resistance Level
- ALC $77.01
- ONC $320.35
- Average True Range (ATR)
- ALC 1.02
- ONC 7.01
- MACD
- ALC 0.07
- ONC -1.29
- Stochastic Oscillator
- ALC 28.44
- ONC 21.90
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.